Top Dividend Stocks To Follow Today – May 14th

Direxion Daily TSLA Bull 2X Shares, ProShares UltraPro Short QQQ, and AbbVie are the three Dividend stocks to watch today, according to MarketBeat’s stock screener tool. Dividend stocks are shares in companies that regularly distribute a portion of their earnings to shareholders, typically in the form of cash payments or additional shares. They provide investors with a predictable income stream and can help balance a portfolio’s total return through both dividends and potential share-price appreciation. Because of their income focus, dividend stocks are often favored by investors seeking steady returns or retirement income. These companies had the highest dollar trading volume of any Dividend stocks within the last several days.

Direxion Daily TSLA Bull 2X Shares (TSLL)

Shares of Direxion Daily TSLA Bull 2X Shares stock traded up $1.27 on Wednesday, hitting $15.38. 238,045,294 shares of the company traded hands, compared to its average volume of 92,817,513. The company has a market cap of $7.22 billion, a P/E ratio of 60.69 and a beta of 2.63. The firm’s 50-day simple moving average is $9.34 and its 200 day simple moving average is $18.32. Direxion Daily TSLA Bull 2X Shares has a 12-month low of $6.29 and a 12-month high of $41.50.

ProShares UltraPro Short QQQ (SQQQ)

ProShares UltraPro Short QQQ (the Fund) seeks daily investment results, which corresponds to three times the inverse of the daily performance of the NASDAQ-100 Index (the Index). The Index includes 100 of the non-financial domestic and international issues listed on National Association of Securities Dealers Automated Quotation (NASDAQ) Stock Market.

NASDAQ:SQQQ traded down $0.38 during trading hours on Wednesday, reaching $23.78. The company’s stock had a trading volume of 79,295,537 shares, compared to its average volume of 53,761,118. The firm has a 50-day simple moving average of $36.08 and a 200-day simple moving average of $32.62. ProShares UltraPro Short QQQ has a 1 year low of $23.67 and a 1 year high of $57.95.

AbbVie (ABBV)

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers.

AbbVie stock traded down $9.22 during trading hours on Wednesday, reaching $178.78. The stock had a trading volume of 6,477,468 shares, compared to its average volume of 6,179,414. The stock has a market cap of $316.26 billion, a PE ratio of 74.49, a PEG ratio of 1.62 and a beta of 0.56. AbbVie has a 52 week low of $153.58 and a 52 week high of $218.66. The company has a debt-to-equity ratio of 17.94, a current ratio of 0.66 and a quick ratio of 0.55. The company has a fifty day simple moving average of $193.34 and a 200-day simple moving average of $187.23.